Sunday, July 31st, 2011 at
Treatment with pregabalin significantly improved sleep and pain in patients with fibromyalgia, according to research presented at the 63rd annual meeting of the American Academy of Neurology, in Honolulu (S27.003).
According to the researchers the improvement in total sleep time was comparable to that seen with standard, FDA-approved sleep-promoting agents such as zolpidem [Ambien, Sanofi-aventis] or eszopiclone [Lunesta, Sunovion Pharmaceuticals],
The researchers enrolled 119 patients, 103 of who were women, to treatment with pregabalin (300-450 mg per day) or placebo in a randomized double-blind fashion. Patients had a mean age of 48.4 years. Dose adjustment took place in the first 14 days, followed by maintenance dosing until day 29. After a two-week taper and washout period, patients repeated the protocol in the other study arm. Read the rest of this entry
Saturday, July 30th, 2011 at
A recently concluded research study was attempted with the objective of determining direct and indirect costs of sleep-disordered breathing (snoring, sleep apnea (SA) and obesity hypoventilation syndrome (OHS)) and the treatment are incompletely described.
Using data from the Danish National Patient Registry (1998–2006), 12 045, 19 438 and 755 patients were identified with a diagnosis of snoring, SA and OHS, respectively. For every patient, four age-, sex- and socioeconomic-matched citizens were randomly selected (48 180, 77 752 and 3020, respectively) from the Danish Civil Registration System Statistics Direct costs were extracted from the Danish Ministry of Health, Danish Medicines Agency and National Health Security and indirect costs were based on data derived from the Coherent Social Statistics. Read the rest of this entry
Friday, July 29th, 2011 at
Many mothers and wives often say one of the things they miss since motherhood began is a good night’s sleep. There are many culprits that steal Mom’s restful time, but one of the biggest can be a snoring partner. But there’s a solution called VitalSleep Stop Snoring Mouthpiece that’s affordable for husbands who snore,and their wives who are kept awake.
“Restful sleep never happens for a snorer… or the people who love them,” says entrepreneur David Hernandez, “And it’s usually the woman who’s kept awake because, scientifically, men are twice as likely to be snorers than women. When every night consists of a nudge here, and a poke there, VitalSleep can end the war some wives face to get a good night’s rest.”
Upon a visit to the dentist to uncover a solution to his snoring, he was prescribed a mouthpiece that allows more air to flow freely to alleviate snoring. The problem is the device came with a huge price tag of $3,000. He asked his doctor for a more economical solution, but there wasn’t one, so that’s when Hernandez conferred with Dr. Richard Koffler M.D. Read the rest of this entry
Wednesday, July 27th, 2011 at
A new study by researchers at Stanford University, using a technique that manipulates light to control brain cells, has shown that broken sleep causes memory impairment in mice.
Until recently scientists have been unable to separate the effects on the brain of different sleep patterns. But in the newest study, they were able to overcome that problem using the new method, known as optogenetics.
Published in the Proceedings of the National Academy of Sciences (PNAS), the study could help explain memory problems linked to conditions including Alzheimer’s and sleep apnea.
The new study looked at sleep that was fragmented, but not shorter or less intense than normal for the mice. They targeted a type of brain cell that plays a vital role in switching between the states of being asleep and being awake. Read the rest of this entry
Friday, July 22nd, 2011 at
What looks like a pacemaker for the heart, may be the ticket for a good night’s sleep. An experimental treatment for Obstructive Sleep Apnea is being tested at the Medical University of South Carolina, where doctors have performed one of only six surgeries in the United States, as part of a trial monitored by the Food and Drug Administration. The experimental treatment works by stimulating muscles to keep the airway from closing off.
Five percent of men and three percent of women in this country suffer Obstructive Sleep Apnea. The numbers dramatically increase as people age. People with Obstructive Sleep Apnea often snore loudly, don’t sleep well at night and feel tired during the day. It can lead to depression, irritability and memory troubles. But it also has the long term risk of stroke, heart disease, high blood pressure and increased risk of automobile accidents.” Read the rest of this entry
Friday, July 22nd, 2011 at
There are many factors that may cause trouble sleeping at night and even lead to chronic insomnia. You’ve probably heard about the basic principles of good sleep hygiene, like not drinking too much caffeine during the day, not exercising late at night and not reading or watching TV in bed if you have trouble sleeping. But good sleep hygiene alone may not solve your sleep problem, especially if there is an underlying issue that hasn’t yet been discovered. If you aren’t sure what’s keeping you up at night, it’s a good idea to rule out some of these common sources for sleep problems. [ Read complete post By Stephanie Silberman At HuffingtonPost … ]
Friday, July 22nd, 2011 at
Nancy Collop, MD, director of the Emory Sleep Center and professor of Medicine and Neurology at Emory University School of Medicine
Nancy A. Collop, MD, director of the Emory Sleep Center and professor of Medicine and Neurology at Emory University School of Medicine, became the 26th president of the American Academy of Sleep Medicine (AASM) in June. Her one-year term as president of the board of directors began Monday, June 13, 2011, at the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS) in Minneapolis, Minn.
A renowned sleep specialist and recognized expert in sleep-related breathing disorders, Collop will provide leadership for the professional society, representing more than 9,000 physicians, scientists and allied-health professionals in the field of sleep medicine.
“It is a privilege and an honor to lead a professional society that has been the catalyst for growth and development in the sleep field during the past four decades,” said Collop. “As president, I will ensure that the AASM continues to promote the highest standards of medical care for patients with sleep disorders while also supporting the scientific and clinical advances that will lead to diagnostic and therapeutic innovations in the future.” Read the rest of this entry
Thursday, July 21st, 2011 at
The global respiratory devices market is forecast to grow from $4.5 billion in 2010 to $7.1 billion by 2017, according to a new report available on companiesandmarkets.com. Read the rest of this entry
Wednesday, July 20th, 2011 at
Sleep Group Solutions (SGS), a leader in dental sleep medicine continuing education and sleep apnea (OSA) screening technology is launching a sleep study club, like no other. Sleep Group Solutions has revolutionized the sleep industry by incorporating top level education, client support, innovating technologies, and now, a common ground to set the bar high in dental offices across the globe.
Dr. Michael Hnat, a dentist in Pittsburgh has been screening and treating his patients for sleep apnea for the past 4 years. As a dentist, Dr. Hnat feels the airway is his responsibility, and each patient gets an evaluation, whether they know it or not. “We screen each patient with forms, and a visual exam. If the neck, tongue, or even BMI is larger than average, it’s a red flag.” says Dr. Hnat. After obtaining many successful cases, Dr. Hnat is a leader in his community in the fight against OSA. When approached by Sleep Group Solutions to lead a study club in his state, Dr. Hnat was excited to even the playing field. Read the rest of this entry
Wednesday, July 20th, 2011 at
SleepApneaDisorder/[ Press Release ]/ BELMONT, Calif. and HYDERABAD, India, July 20, 2011 /- Ventus Medical is pleased to announce the Indian launch of its proprietary Provent® Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea (OSA). Orbees Business Solutions Pvt. Ltd. will be the strategic market developer of Provent Therapy in India.
“India has a very high prevalence of obstructive sleep apnea. Roughly 20% of urban Indian males suffer from OSA,” said Rajiv Doshi, M.D., Chief Scientific Officer of Ventus Medical and inventor of the Provent technology. Dr. Doshi is faculty at Stanford University and serves as Executive Director (US) of the Stanford India Biodesign program, a Government of India funded collaboration between Stanford University and the All India Institute of Medical Sciences (AIIMS) and the Indian Institute of Technology Delhi. “With a very large patient need, we believe that Provent Therapy provides a reliable and clinically-proven solution to treat the millions of people in India with OSA.” Read the rest of this entry